EMD 281014, a new selective serotonin 5-HT2A receptor antagonist (Q34218905)

31 July 2017

title

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist (English)

1 reference

31 July 2017

Gerd D Bartoszyk

1

1 reference

31 July 2017

Christoph van Amsterdam

series ordinal

2

1 reference

31 July 2017

Henning Böttcher

series ordinal

3

1 reference

31 July 2017

Christoph A Seyfried

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

European Journal of Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

473

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

229-230

1 reference

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901992-7

Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901992-7

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901992-7

The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901992-7

Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901992-7

10.1016/S0014-2999(03)01992-7

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference